During the past decade, Hallym University Dongtan Sacred Heart Hospital conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 7 clinical trials were completed, i.e. on average, 18.4% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 7 clinical trials were completed. i.e. 41.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hallym University Dongtan Sacred Heart Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Asan Medical Center" with 2 trials sponsored, "Dongtan Sacred Heart Hospital" with 2 trials sponsored and "Gangnam Severance Hospital" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hallym University Dongtan Sacred Heart Hospital" #1 collaborator was "Korean Cancer Study Group" with 2 trials as a collaborator, "BioShin Limited" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Dt&Sanomedics" with 1 trials as a collaborator and "Health Insurance Review & Assessment Service" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hallym University Dongtan Sacred Heart Hospital" are "Breast Cancer" (4 trials), "Crohn's Disease" (2 trials), "Hepatitis C Virus" (2 trials), "Influenza A" (2 trials) and "Ischemic Stroke" (2 trials). Many other conditions were trialed in "Hallym University Dongtan Sacred Heart Hospital" in a lesser frequency.

Most popular intervention types in "Hallym University Dongtan Sacred Heart Hospital" are "Drug" (28 trials), "Device" (7 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Guselkumab" (3 trials), "Golimumab" (2 trials), "JNJ-78934804" (2 trials) and "Pimodivir 600 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hallym University Dongtan Sacred Heart Hospital" are 40 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hallym University Dongtan Sacred Heart Hospital". undefined are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Hallym University Dongtan Sacred Heart Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hallym University Dongtan Sacred Heart Hospital, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".